Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines
Open Access
- 25 November 2010
- journal article
- research article
- Published by BMJ in Tobacco Control
- Vol. 20 (3), e2
- https://doi.org/10.1136/tc.2010.037465
Abstract
Objective Oral tobacco products contain nicotine and carcinogenic tobacco-specific N-nitrosamines (TSNAs) that can be absorbed through the oral mucosa. The aim of this study was to determine typical pH ranges and concentrations of total nicotine, unionised nicotine (the most readily absorbed form) and five TSNAs in selected oral tobacco products distributed globally. Methods A total of 53 oral tobacco products from 5 World Health Organisation (WHO) regions were analysed for total nicotine and TSNAs, including 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), using gas chromatography or liquid chromatography with mass spectrometric detection. Unionised nicotine concentrations were calculated using product pH and total nicotine concentrations. Fourier transform infrared spectroscopy was used to help categorise or characterise some products. Results Total nicotine content varied from 0.16 to 34.1 mg/g product, whereas, the calculated unionised nicotine ranged from 0.05 to 31.0 mg/g product; a 620-fold range of variation. Products ranged from pH 5.2 to 10.1, which translates to 0.2% to 99.1% of nicotine being in the unionised form. Some products have very high pH and correspondingly high unionised nicotine (eg, gul powder, chimó, toombak) and/or high TSNA (eg, toombak, zarda, khaini) concentrations. The concentrations of TSNAs spanned five orders of magnitude with concentrations of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) ranging from 4.5 to 516 000 ng/g product. Conclusions These data have important implications for risk assessment because they show that very different exposure risks may be posed through the use of these chemically diverse oral tobacco products. Because of the wide chemical variation, oral tobacco products should not be categorised together when considering the public health implications of their use.Keywords
This publication has 10 references indexed in Scilit:
- Effect of Differing Levels of Tobacco-Specific Nitrosamines in Cigarette Smoke on the Levels of Biomarkers in SmokersCancer Epidemiology, Biomarkers & Prevention, 2010
- Rapid and Chemically Selective Nicotine Quantification in Smokeless Tobacco Products using GC-MSJournal of Chromatographic Science, 2009
- New and traditional smokeless tobacco: Comparison of toxicant and carcinogen levelsNicotine & Tobacco Research, 2008
- Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosaminesNicotine & Tobacco Research, 2008
- Similar Exposure to a Tobacco-Specific Carcinogen in Smokeless Tobacco Users and Cigarette SmokersCancer Epidemiology, Biomarkers & Prevention, 2007
- Smokeless tobacco and health in India and South AsiaRespirology, 2003
- Pharmacokinetics and pharmacodynamics of moist snuff in humansTobacco Control, 1999
- Review of the evidence that pH is a determinant of nicotine dosage from oral use of smokeless tobaccoTobacco Control, 1997
- Carcinogenic tobacc-specific nitrosamines are present at unusually high levels in the saliva of oral snuff users in SudanCarcinogenesis: Integrative Cancer Research, 1992
- Unusually high levels of carcinogenic tobacco-specific nitrosamines in Sudan snuff (toombak)Carcinogenesis: Integrative Cancer Research, 1991